Switch to:
More From Other Websites
Better Buy: Exelixis, Inc. vs. Novartis AG Jun 24 2017
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod Jun 23 2017
Novartis breast cancer drug Kisqali wins European panel backing Jun 23 2017
Healthcare Stock Rally Can't Save S&P 500 From Another Bad Day Jun 22 2017
Novartis Pops To 5-Month High On Strong Trial In Heart Attack Survivors Jun 22 2017
Drugmakers May Lose $390B In Sales Over 5 Years Jun 22 2017
Novartis' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price Jun 22 2017
Health stocks help European equities cut losses Jun 22 2017
Healthcare Leads as Stocks Turn Higher After Release of Senate Bill Jun 22 2017
Novartis Announces Positive Results for Cardiovascular Drug Jun 22 2017
Stock Futures Dip as Crude Oil Looks to Correct Days-Long Slide Jun 22 2017
Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation Jun 22 2017
Novartis Shares Lead Swiss Market Higher After CANTOS Trial Success Jun 22 2017
Novartis Migraine Drug Accepted, AMD Positive in Phase III Jun 21 2017
Featured Company News - DURECT-SANDOZ Collaboration Clears HSR Review; Paves Path for POSIMIR... Jun 21 2017
Regeneron Soars After Eye Drug Competitor Novartis Releases Positive Data Jun 20 2017
Could Novartis' Drug Topple Regeneron's Blockbuster Eylea? Jun 20 2017
The (Second) Hottest Stock: Regeneron Pharmaceuticals Jumps 5% Jun 20 2017
Novartis Takes Aim at Regeneron Pharmaceuticals' Eylea Jun 20 2017
Novartis eye drug works with fewer injections than rival Jun 20 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK